ALLK (allakos.com) Net Profit

ALLK (allakos.com) - company brandmark

The marginal income of Allakos Inc. on the GURU.Markets chart demonstrates profit dynamics, where the value -0.07 represents the latest figure. Allakos Inc. aims to expand the application of lireltelimab against inflammation to capture market share. A unique Siglec-8 blocking method helps treat severe allergies. The firm is currently conducting clinical tests of its immune developments independently.

ALLK (Allakos Inc.) Net Profit history from 07/04/2022 to 05/24/2025

Analytical breakdowns and data insights for company allakos.com (ALLK)

- price and consensus price forecast:
Stock Quotes Allakos|ALLK - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization ALLK|ALLK - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Allakos|ALLK - Book Capitalization|Market Capitalization to Book Value allakos.com|ALLK - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Allakos Inc.|ALLK - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Allakos|ALLK - Company Total Debt|Debts to Book Capitalization ALLK|ALLK - Company Long-Term Debt|Company Short-Term Indebtedness Allakos|Immediate Liquidity allakos.com
- net income and valuation multiples indicators:
ALLK - Net Profit
Summary company analysis:Allakos Inc.
Core merchandise of Allakos Inc

Allakos Inc. specializes in developing innovative antibodies for the therapy of inflammatory processes, where capital management efficiency directly impacts clinical success. By analyzing the company's profit metrics, an investor can see the market consensus on operating income, which reflects the immediate market reaction to fundamental events, allowing for the differentiation of sustainable cash flow from risky price bubbles.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|PHAR - Net Profit|Nektar Therapeutics (NKTR) - Company Net Income|UPB (upstreambio.com) - Company Net Income|Company Net Income Zenas Biopharma|Company Net Income IMNM|Net Profit GOSS|Net Profit KalVista Corp (KALV)|Company Net Income Septerna Inc SEPN|Net Profit pieris.com PVLA|SVRA - Company Net Income|Company Net Income Rigel Pharma|AnaptysBio Corp (ANAB) - Company Net Income|ATXS - Net Financial Result|Net Income ENGN|RAPT: Final Profit|Net Profit JBIO|Net Financial Result Aclaris Therapeutics Inc.|Company Net Income Kyverna KYTX|TLSA: Company Profit|Cabaletta Bio, Inc. - Net Profit|ventyxbio.com (VTYX) - Net Income|THTX (Theratechnologies) - Net Income|AVTX - Net Financial Result|ELDN (Eledon) - Net Profit|Net Profit Agenus, Inc|Company Net Income Climb Bio Inc (CLYM)|Company Net Income ZURA (zurabio.com)|Company Net Income aTyr Pharma ATYR|Adagene Inc - Company Net Income|IMA - Company Net Income|STTK - Net Profit|equilliumbio.com (EQ) - Company Net Income|Profit After Tax CNTB (Connect Biopharma Holdings Limited)|IMUX (Immunic Therapeutics) - Net Profit|ATRA: Final Profit|Net Profit IFRX|Net Profit X4 Pharmaceuticals, Inc (XFOR)|Company Net Income Adicet Bio, Inc. ACET|Final Profit CELU|INMB - Company Net Income|Barinthus Biotherapeutics PLC (BRNS) - Net Income|KZR: Net Profit|SAB Biotherapeutics Inc (SABS) - Net Profit|Net Income AKTX|ENLV: Final Profit|Net Profit QTTB|Net Financial Result GeoVax Labs|Company Net Income Edesa EDSA|IBIO - Net Income|CARM - Company Net Income|xtlbio.com (XTLB) - Net Income|BOLT (boltbio.com) - Net Income|HCW Biologics (HCWB) - Net Profit|Company Net Income Aptevo Therapeutics, Inc.|Company Profit AIM (aimimmuno.com)|Net Profit ADTX|GRI - Company Net Income|Net Profit XRTX (XORTX Therapeutics)|Net Profit Vyome Holdings Inc. HIND|REVB - Company Net Income|INDP: Company Net Income|Scinai Immunotherapeutics (SCNI) - Company Net Income|CALI (CalciMedica) - Company Net Income|AFMD (Affimed NV) - Net Profit|Net Profit HOOKIPA|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Profit iTeos Pharma (ITOS)|Company Net Income Ocean Biomedical, Inc. OCEA|tcbiopharm.com (TCBP) - Company Net Income|THRD - Company Net Income